Cargando…
Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) accounts for over 90% of all pancreatic cancer. Nanoparticles (NPs) offer new opportunities for image-guided therapy owing to the unique physicochemical properties of the nanoscale effect and the multifunctional capabilities of NPs. However, major obstacles ex...
Autores principales: | Li, Junjie, Liu, Fengyong, Gupta, Sanjay, Li, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924507/ https://www.ncbi.nlm.nih.gov/pubmed/27375787 http://dx.doi.org/10.7150/thno.15122 |
Ejemplares similares
-
Interventional nanotheranostics in hepatocellular carcinoma
por: Chavda, Vivek P., et al.
Publicado: (2023) -
Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019) -
Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013) -
Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013) -
Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)